CPT1A levels (23.95 ± 12.70 ng/mL) consistently decreased in post-surgery serum samples of breast cancer patients compared with paired pre-surgery samples (Fig. 6a, b, right; 41.40 ± 35.02 ng/mL, p < 0.0001). The gene discussed is CPT1A; the disease is breast carcinoma.